Abstract
Morbidity statistics can be reported as grouped data for health services rather than for individual residence area, especially in low-middle income countries. Although such reports can support some evidence-based decisions, these are of limited use if the geographical distribution of morbidity cannot be identified. This study estimates the spatial rate of Acute respiratory infections (ARI) in census districts in Cúcuta -Colombia, using an analysis of the spatial distribution of health services providers. The spatial scope (geographical area of influence) of each health service was established from their spatial distribution and the population covered. Three levels of spatial aggregation were established considering the spatial scope of primary, intermediate and tertiary health services providers. The ARI cases per census district were then calculated and mapped using the distribution of cases per health services provider and the proportion of population per district in each level respectively. Hotspots of risk were identified using the Local Moran’s I statistic. There were 98 health services providers that attended 8994, 18450 and 91025 ARI cases in spatial levels 1, 2 and 3, respectively. Higher spatial rates of ARI were found in districts in central south; northwest and northeast; and southwest Cúcuta with hotspots of risk found in central and central south and west and northwest Cucuta. The method used allowed overcoming the limitations of health data lacking area of residence information to implementing epidemiological analyses to identify at risk communities. This methodology can be used in socioeconomic contexts where geographic identifiers are not attached to health statistics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the ethics committee of the University of Santander, record VII-FT-025-UDES, 021 25/06/2019.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
There has been rephrasing of some sections in the methods for clarity as the methodology needed further explanation, correction of several spelling mistakes and additional demographic information on the setting of the study. The discussion has some additional references.
Data Availability
All data produced in the study are available upon reasonable request to the authors. The raw data provided by the Department of Health is subject to their authorisation to be published.
